Ping An Insurance (Group) Company of China, Ltd.
+4.00%
3M Return
$1.310
+0.041 (+3.15%)At close
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
Lufax Holding Ltd is currently trading at $1.31, which is below the analyst price target of $1.40 from Deutsche Bank and $2.00 from JPMorgan. However, the stock has an RSI of 33.546, indicating it is in oversold territory, which could suggest a potential rebound. The company has shown a significant decline with a year-to-date change of -51.30%, and while it has regained compliance with NYSE listing standards, the recent management changes may create uncertainty. Therefore, it may be prudent to hold rather than buy at this moment, as the risks outweigh the potential short-term gains.

Lufax Reports Q2 2026 Financial Results Marking Return to Normal Reporting

Lufax Reports Q2 2026 Financial Results with Significant Improvements

Lufax to Release Q2 2026 Financial Results on August 18

Latest Wall Street Rating Changes

Lufax Announces Board and Management Changes
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries. It operates in the Financials sector.
Lufax Holding Ltd is currently trading at $1.31, which is below the analyst price target of $1.40 from Deutsche Bank and $2.00 from JPMorgan. However, the stock has an RSI of 33.546, indicating it is in oversold territory, which could suggest a potential rebound. The company has shown a significant decline with a year-to-date change of -51.30%, and while it has regained compliance with NYSE listing standards, the recent management changes may create uncertainty. Therefore, it may be prudent to hold rather than buy at this moment, as the risks outweigh the potential short-term gains.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.